{"id":"W2560280991","doi":"10.1089/dia.2016.0261","title":"Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1)","year":2016,"lang":"en","type":"article","venue":"Diabetes Technology & Therapeutics","topic":"Diabetes Management and Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Placebo; Insulin; Diabetes mellitus; Interquartile range; Internal medicine; Type 2 diabetes; Endocrinology; Hypoglycemia; Type 1 diabetes","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001758576,0.0005545284,0.001950525,0.0006919901,0.0001054592,0.00007605035,0.0007442978,0.0004524443,0.00005750787],"category_scores_gemma":[0.001030678,0.0003092928,0.00008475513,0.0009656684,0.0008264394,0.0002483995,0.000574379,0.0005588305,0.00005262081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001280492,"about_ca_system_score_gemma":0.0001517521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001320809,"about_ca_topic_score_gemma":0.00001684132,"domain_scores_codex":[0.9960409,0.0004624099,0.0007365013,0.001115198,0.0006553274,0.0009896632],"domain_scores_gemma":[0.9956947,0.001574982,0.0002566299,0.001863748,0.0003742012,0.0002357664],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4631112,0.001166127,0.4904414,0.00003482701,0.001596857,0.00001190921,0.00007488717,7.464539e-7,0.001595134,0.00002412777,0.00001299236,0.04192984],"study_design_scores_gemma":[0.9537261,0.007469324,0.02875732,0.0006465082,0.001370859,1.7772e-7,0.00009708237,0.000190334,0.005675997,0.0008806462,0.0006731732,0.0005125396],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875982,0.00165874,0.00004397767,0.001932768,0.0002691548,0.008102139,0.00006354244,0.000243369,0.00008804628],"genre_scores_gemma":[0.9970621,0.0002031504,0.001146141,0.0003897186,0.000141245,0.0007261169,0.00009265774,0.00009148809,0.0001474233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4906149,"threshold_uncertainty_score":0.9999359,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01842688632414799,"score_gpt":0.2678732901847652,"score_spread":0.2494464038606173,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}